Co-Diagnostics Price to Free Cash Flow Ratio 2017-2023 | CODX
Co-Diagnostics Price to Free Cash Flow Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
2024-05-01 | 1.19 | 0.00 | |
2023-12-31 | 1.33 | $-0.80 | 0.00 |
2023-09-30 | 1.06 | $-0.76 | 0.00 |
2023-06-30 | 1.11 | $-0.49 | 0.00 |
2023-03-31 | 1.48 | $-0.24 | 0.00 |
2022-12-31 | 2.52 | $0.16 | 15.43 |
2022-09-30 | 3.21 | $0.46 | 6.94 |
2022-06-30 | 5.61 | $0.80 | 7.04 |
2022-03-31 | 6.18 | $1.16 | 5.32 |
2021-12-31 | 8.93 | $1.35 | 6.61 |
2021-09-30 | 9.73 | $1.90 | 5.12 |
2021-06-30 | 8.25 | $1.81 | 4.55 |
2021-03-31 | 9.54 | $1.45 | 6.60 |
2020-12-31 | 9.30 | $0.98 | 9.51 |
2020-09-30 | 13.59 | $0.16 | 84.57 |
2020-06-30 | 19.35 | $-0.19 | 0.00 |
2020-03-31 | 7.62 | $-0.31 | 0.00 |
2019-12-31 | 0.90 | $-0.34 | 0.00 |
2019-09-30 | 1.03 | $-0.31 | 0.00 |
2019-06-30 | 0.80 | $-0.33 | 0.00 |
2019-03-31 | 1.06 | $-0.34 | 0.00 |
2018-12-31 | 1.49 | $-0.33 | 0.00 |
2018-09-30 | 2.63 | $-0.36 | 0.00 |
2018-06-30 | 3.88 | $-0.46 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.036B | $0.007B |
Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $122.851B | 15.41 |
Cencora (COR) | United States | $47.686B | 19.03 |
ICON (ICLR) | Ireland | $24.574B | 23.20 |
DiDi Global (DIDIY) | China | $24.011B | 0.00 |
Avantor (AVTR) | United States | $16.459B | 24.23 |
Viatris (VTRS) | United States | $13.776B | 3.96 |
CochLear (CHEOY) | Australia | $13.705B | 0.00 |
Revvity (RVTY) | United States | $12.658B | 22.18 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $12.086B | 0.00 |
Medpace Holdings (MEDP) | United States | $12.032B | 39.59 |
Charles River Laboratories (CRL) | United States | $11.796B | 21.50 |
Natera (NTRA) | United States | $11.354B | 0.00 |
Solventum (SOLV) | United States | $11.215B | 0.00 |
Sonic Healthcare (SKHHY) | Australia | $8.201B | 0.00 |
HealthEquity (HQY) | United States | $6.770B | 50.58 |
Bausch + Lomb (BLCO) | Canada | $5.109B | 19.65 |
Organon (OGN) | United States | $4.786B | 4.61 |
Doximity (DOCS) | United States | $4.531B | 33.74 |
PACS (PACS) | United States | $3.749B | 0.00 |
Surgery Partners (SGRY) | United States | $3.171B | 29.35 |
Sotera Health (SHC) | United States | $3.170B | 15.56 |
Progyny (PGNY) | United States | $3.081B | 51.71 |
GoodRx Holdings (GDRX) | United States | $2.804B | 142.00 |
Life Times (LTH) | United States | $2.687B | 29.70 |
Premier (PINC) | United States | $2.502B | 9.16 |
AMN Healthcare Services Inc (AMN) | United States | $2.273B | 7.35 |
Agilon Health (AGL) | United States | $2.261B | 0.00 |
Teladoc Health (TDOC) | United States | $2.162B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.830B | 0.00 |
Agiliti (AGTI) | United States | $1.381B | 22.56 |
Establishment Labs Holdings (ESTA) | $1.373B | 0.00 | |
NovoCure (NVCR) | Jersey | $1.317B | 0.00 |
Alignment Healthcare (ALHC) | United States | $0.982B | 0.00 |
Pediatrix Medical (MD) | United States | $0.745B | 7.71 |
Embecta (EMBC) | United States | $0.583B | 3.85 |
COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
Enhabit (EHAB) | United States | $0.506B | 45.86 |
Auna S.A (AUNA) | Luxembourg | $0.503B | 0.00 |
LifeMD (LFMD) | United States | $0.488B | 0.00 |
InnovAge Holding (INNV) | United States | $0.482B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.445B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.437B | 0.00 |
MultiPlan (MPLN) | United States | $0.419B | 0.00 |
CareDx (CDNA) | United States | $0.402B | 0.00 |
Beauty Health (SKIN) | United States | $0.399B | 0.00 |
Sera Prognostics (SERA) | United States | $0.379B | 0.00 |
DocGo (DCGO) | United States | $0.352B | 56.33 |
ModivCare (MODV) | United States | $0.333B | 4.42 |
Ascend Wellness Holdings (AAWH) | United States | $0.304B | 0.00 |
Sharecare (SHCR) | United States | $0.259B | 0.00 |
Biodesix (BDSX) | United States | $0.142B | 0.00 |
So-Young (SY) | China | $0.129B | 43.33 |
Oncology Institute (TOI) | United States | $0.079B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
NeueHealth (NEUE) | United States | $0.052B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.036B | 0.00 |
Nutex Health (NUTX) | United States | $0.030B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
DermTech (DMTK) | United States | $0.021B | 0.00 |
OncoCyte (OCX) | United States | $0.021B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.007B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.007B | 0.00 |
OpGen (OPGN) | United States | $0.005B | 0.00 |
Assure Holdings (IONM) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |